首页> 外文期刊>Therapeutic Drug Monitoring >Dose-adjusted cyclosporine c2 in a patient with jejunoileal bypass as compared to seven other liver transplant recipients.
【24h】

Dose-adjusted cyclosporine c2 in a patient with jejunoileal bypass as compared to seven other liver transplant recipients.

机译:与其他七名肝移植受者相比,空肠旁路手术患者的剂量调整后的环孢素c2。

获取原文
获取原文并翻译 | 示例
           

摘要

Jejunoileal bypass (JIB) is a weight loss procedure in which malabsorption is produced by connecting a short length of proximal jejunum to the distal ileum. Because 90% of the small intestine is bypassed, it may have impact on the dose-concentration response of oral cyclosporine (CsA). The authors characterized the dose-adjusted blood concentrations of CsA obtained 2 hours (C2) after oral microemulsion CsA (ME-CsA) in a liver transplant (LTx) subject with an intact JIB, as compared with those from seven LTx controls without JIB. The biliary reconstruction involved choledochocholedochostomy without external drainage in all patients. ME-CsA was administered via a nasogastric tube within 24 hours after graft reperfusion. Oral fluconazole was given prophylactically to the study subject only for 6 days after LTx. During the first week after LTx, the dose-adjusted C2 (mean +/- SD) for the study subject and for controls was 53 +/- 10 and 106 +/- 47 ng/mL, respectively (P < 0.001). The corresponding value during the period from day 7 to day 107 was 105 +/- 40 and 257 +/- 86 ng/mL, respectively (P < 0.001). Multiple linear regression revealed that dosage, days after LTx, and the presence of a JIB were all independent predictors of C2 (R2 = 0.798, P = 0.037). Lack of bile resulting in malabsorption of ME-CsA was not thought to be significant contributor to her low dose-adjusted C2 because there was no external bile drainage and a portion of terminal ileum, where most bile acid reabsorption occurred, was still available after JIB. The fact that fluconazole failed to increase the dose-adjusted C2 in the study subject supports that enteric clearance of CsA may become clinically unimportant after JIB. Therefore, the low dose-adjusted C2 is most likely explained by the reduced bowel length and associated absorptive surface area after JIB. In conclusion, patients with JIB may require higher doses of ME-CsA.
机译:空肠回肠旁路术(JIB)是一种减肥过程,其中通过将较短长度的空肠近端连接至回肠远端而产生吸收不良。因为绕过了90%的小肠,所以它可能对口服环孢素(CsA)的剂量浓度反应产生影响。这组作者描述了在具有完整JIB的肝移植(LTx)受试者中,口服微乳剂CsA(ME-CsA)2小时后(C2)获得的剂量调整后的CsA血药浓度,与来自七个没有JIB的LTx对照的人相比。在所有患者中,胆道重建均需进行胆总管吻合术而无需外部引流。移植物再灌注后24小时内,通过鼻胃管给予ME-CsA。仅在LTx后6天内预防性给予口服氟康唑。在LTx后的第一周内,研究对象和对照组的剂量调整后C2(平均值+/- SD)分别为53 +/- 10 ng和106 +/- 47 ng / mL(P <0.001)。从第7天到第107天的相应值分别为105 +/- 40 ng / mL和257 +/- 86 ng / mL(P <0.001)。多元线性回归显示,LTx给药后几天,JIB的存在与否都是C2的独立预测因子(R2 = 0.798,P = 0.037)。胆汁不足导致ME-CsA吸收不良被认为不是其低剂量调整后C2的重要原因,因为在JIB后没有外部胆汁引流且部分末端回肠(大部分发生胆汁酸重吸收)仍然存在。 。氟康唑未能增加研究对象的剂量调整后的C2的事实支持CIB的肠清除率在JIB后可能在临床上不重要。因此,低剂量调整后的C2最有可能是由于JIB后肠长度减少和相关的吸收表面积减少所致。总之,JIB患者可能需要更高剂量的ME-CsA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号